Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia

詳細情報 詳細情報について

• CRID

  1361699993654284288

• DOI

  10.1007/s12185-013-1483-9

• ISSN

  18653774

  09255710

• Web Site

  http://link.springer.com/content/pdf/10.1007/s12185-013-1483-9.pdf

  http://link.springer.com/article/10.1007/s12185-013-1483-9/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s12185-013-1483-9

• データソース種別

  • Crossref